AFP and Cirrhosis: Recently osteopontin (OPN) attracted attention as a promising biomarker for HCC diagnosis in patients with virus related cirrhosis with better sensitivity than AFP in differentiating HCC cases from cirrhosis controls as suggested by the results of two major studies [27, 36], which included patients with liver disease, particularly chronic HBV or HCV infections.